Tested on animal models by a team of researchers from the San Raffaele-Telethon Institute of Gene Therapy in Milan, it promises to increase the number of patients and diseases for which gene therapy could be a concrete option
Subscribe to our newsletter to stay informed†
A team of researchers from the San Raffaele-Telethon Institute of Gene Therapy in Milan has developed a new therapeutic protocol, currently experimental, that would make it possible to overcome one of the limits that hinder the use of stem cell transplantation for gene therapy. have to administer chemotherapy drugs before the correct version of their cells is re-administered to patients. As detailed in the pages of the specialist journal Cell, Sr-Tiget researchers have combined molecular approaches and innovative techniques based on messenger RNA, yielding a new “safer and less grueling protocol”, tested on animal models, that the public of patients and pathology for which gene therapy could be a concrete option.
Source: TG 24 Sky
I am James Novak, a passionate and experienced news writer with the ultimate goal of delivering the most accurate and timely information to my readers. I work in the news department at a website dedicated to providing reliable and up-to-date information about technology. My articles are widely circulated, often featured on major publications, and have been read by millions of people around the world. With over four years of writing experience in various fields such as tech startups, industry trends, cybersecurity, AI/ML advances, and more, I bring an informed perspective to all topics I write on. Beyond my published work online and in print media outlets, I’m also an avid speaker at local events where I share my insights on current issues related to technology.